Objective: To evaluate the effects of Baduanjin on quality of life (QOL), psychological status and cardiac function of patients with coronary heart disease after percutaneous coronary intervention (PCI). Methods: PubMed, The Cochrance Library, Embase, Web of Science, China Biology Medicine disc, CNKI, VIP and Wanfang were searched by a computer for any randomized controlled trials of Baduanjin intervention in patients with coronary heart disease after PCI, including relevant conference articles and academic papers published in journals. The retrieval time was from the database creation time to September 7, 2020. After two evaluators independently screened the literature, extracted relevant data and evaluated the bias risk for the included studies, RevMan5.3 software was used for a data analysis. Results:A total of 9 articles and 846 patients were included. The meta-analysis showed that the Baduanjin group was superior to the conventional western medicine treatment group in physical hunctioning、role-physical 、general health、role-emotional 、mental health、 anxiety、 anxiety、left ventricular ejection fraction、blood pressure、stroke volume，and the differences were statistically significant.But the Baduanjin group was not superior to the control group in bodily pain、vitality、social functioning,and the differences were not statistically significant. Conclusion: Baduanjin can improve the cardiac function, regulate the psychological state and improve the QOL among patients with coronary heart disease after PCI.